743304779	743304779	CD	B-NP	O
|	|	NN	I-NP	O
BMC	BMC	NN	I-NP	O
|	|	NN	I-NP	O
86191518	86191518	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6818665	6818665	CD	B-NP	O
|	|	CC	I-NP	O
8/5/2004	8/5/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/5/2004	8/5/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/26/2005	5/26/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
QUINCY	QUINCY	NNP	B-NP	O
BRIDENBAUGH	BRIDENBAUGH	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypoglycemia	Hypoglycemia	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Altered	Alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Volume	Volume	NN	B-NP	O
overload	overload	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Possible	Possible	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Bilateral	Bilateral	JJ	B-NP	O
occipital	occipital	NN	I-NP	O
CVAs	CVA	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Visual	Visual	JJ	B-NP	O
impair	impair	NN	I-NP	O
with	with	IN	B-PP	O
tunnel	tunnel	NN	B-NP	O
vision	vision	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Monoclonal	Monoclonal	JJ	B-NP	O
gammopathy	gammopathy	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Bilateral	Bilateral	JJ	B-NP	O
occipital	occipital	NN	I-NP	O
CVAs	CVA	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
thrombophlebitis	thrombophlebitis	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Microcytic	Microcytic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
by	by	IN	B-PP	O
home	home	NN	B-NP	O
services	service	NNS	I-NP	O
and	and	CC	O	O
home	home	NN	B-NP	O
nursing	nursing	NN	I-NP	O
with	with	IN	B-PP	O
confusion	confusion	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
was	be	VBD	B-VP	O
37	37	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
42	42	CD	B-NP	O
with	with	IN	B-PP	O
orange	orange	NN	B-NP	O
juice	juice	NN	I-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
quite	quite	RB	B-NP	O
some	some	DT	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
taken	take	VBN	I-VP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Novolin	Novolin	NNP	B-NP	O
40	40	CD	I-NP	O
units	unit	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
noted	note	VBN	I-VP	O
increasing	increase	VBG	B-VP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
nocturia	nocturia	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
ambulatory	ambulatory	JJ	I-NP	O
sat	sat	NN	I-NP	O
was	be	VBD	B-VP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Glucose	Glucose	NN	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
low	low	JJ	B-ADJP	O
and	and	CC	O	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	O	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
consolidation	consolidation	NN	I-NP	O
versus	versus	IN	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
Levaquin	Levaquin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
propoxyphene	propoxyphene	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o	p.o	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Amitriptyline	Amitriptyline	NN	B-NP	O
25	25	CD	I-NP	O
to	to	TO	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Multivitamins	Multivitamin	NNS	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Novolin	Novolin	NN	B-NP	O
34	34	CD	I-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.d.	q.d.	RB	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Epogen	Epogen	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.	q.	LS	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
70s	70	NNS	I-NP	O
,	,	,	O	O
mother	mother	NN	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hematologic	hematologic	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
thalassemia	thalassemia	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
knows	know	NNS	I-NP	O
of	of	IN	B-PP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
assisted	assist	VBN	I-NP	O
living	live	VBG	I-NP	O
facility	facility	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
extensive	extensive	JJ	B-NP	O
home	home	NN	I-NP	O
care	care	NN	I-NP	O
services	service	NNS	I-NP	O
and	and	CC	I-NP	O
lives	life	NNS	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
children	child	NNS	B-NP	O
who	who	WP	B-NP	O
live	live	VBP	B-VP	O
nearby	nearby	RB	B-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
95.2	95.2	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
111/69	111/69	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
73	73	CD	I-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
and	and	CC	I-NP	O
mentation	mentation	NN	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	I-VP	O
across	across	VB	I-VP	O
her	her	PRP$	B-NP	O
precordium	precordium	NN	I-NP	O
.	.	.	O	O

Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	O	O
decreased	decrease	VBN	B-NP	O
phrenitis	phrenitis	NN	I-NP	O
,	,	,	O	O
wheezing	wheeze	VBG	B-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
lung	lung	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
benign	benign	JJ	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
bilateral	bilateral	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
symmetric	symmetric	JJ	I-ADJP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
moving	move	VBG	I-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
eye	eye	NN	I-NP	O
with	with	IN	B-PP	O
slight	slight	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
deviation	deviation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equally	equally	RB	B-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Evidence	Evidence	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
cataract	cataract	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
BNP	BNP	NN	B-NP	O
of	of	IN	B-PP	O
1111	1111	NN	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
2.4	2.4	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
below	below	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
2.6	2.6	CD	B-NP	O
to	to	TO	B-PP	O
2.8	2.8	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
6.6	6.6	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
left	left	JJ	I-NP	O
shift	shift	NN	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
was	be	VBD	B-VP	O
35.7	35.7	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
27	27	CD	B-NP	O
to	to	TO	B-PP	O
33	33	CD	B-NP	O
.	.	.	O	O

MCV	MCV	NN	B-NP	O
was	be	VBD	B-VP	O
67.4	67.4	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
range	range	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
in	in	IN	B-PP	O
5/25	5/25	CD	B-NP	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	O
gammopathy	gammopathy	NN	I-NP	O
on	on	IN	B-PP	O
SPEP	SPEP	NN	B-NP	B-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
inferoseptal	inferoseptal	JJ	I-NP	O
Q	Q	NN	I-NP	O
wave	wave	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
R	R	NN	I-NP	O
wave	wave	NN	I-NP	O
progression	progression	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
in	in	IN	B-PP	O
5/25	5/25	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
50	50	CD	B-NP	O
to	to	TO	I-NP	O
55	55	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
moderate-to-severe	moderate-to-severe	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	I-NP	O
TR	TR	NN	I-NP	B-protein
,	,	,	O	O
septal	septal	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
as	as	IN	B-PP	O
describes	describe	NNS	B-NP	O
above	above	IN	B-PP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
low	low	JJ	B-NP	O
likelihood	likelihood	NN	I-NP	O
for	for	IN	B-PP	O
having	have	VBG	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
more	more	RBR	I-VP	O
likely	likely	RB	I-VP	O
have	have	VB	I-VP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
visual	visual	JJ	I-NP	O
problems	problem	NNS	I-NP	O
and	and	CC	O	O
declining	decline	VBG	B-NP	O
physical	physical	JJ	I-NP	O
condition	condition	NN	I-NP	O
and	and	CC	I-NP	O
deconditioning	deconditioning	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
current	current	JJ	I-NP	O
living	living	NN	I-NP	O
situation	situation	NN	I-NP	O
and	and	CC	I-NP	O
arrangements	arrangement	NNS	I-NP	O
are	be	VBP	B-VP	O
possibly	possibly	RB	B-ADJP	O
insufficient	insufficient	JJ	I-ADJP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
increasing	increase	VBG	B-VP	O
needs	need	NNS	B-NP	O
and	and	CC	I-NP	O
error	error	NN	I-NP	O
in	in	IN	B-PP	O
self	self	NN	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
medications	medication	NNS	B-NP	O
or	or	CC	O	O
increasing	increase	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
or	or	CC	O	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
precipitated	precipitate	VBN	I-VP	O
her	her	PRP$	B-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
episode	episode	NN	I-NP	O
and	and	CC	O	O
altered	alter	VBD	B-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
ID/Pulmonary	ID/Pulmonary	NNP	B-NP	O
:	:	:	O	O
Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
versus	versus	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-NP	O
consolidated	consolidated	JJ	I-NP	O
lobar	lobar	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
good	good	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
and	and	CC	I-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
toxicity	toxicity	NN	B-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	O	O
gram	gram	NN	B-NP	O
stein	stein	NN	I-NP	O
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Pleural	Pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
only	only	RB	B-ADVP	O
minimally	minimally	RB	I-ADVP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
liters	liter	NNS	I-NP	O
overnight	overnight	RB	B-ADVP	O
and	and	CC	O	O
for	for	IN	B-PP	O
diagnostic	diagnostic	JJ	B-NP	O
and	and	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
purposes	purpose	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
on	on	IN	B-PP	O
3/1/05	3/1/05	CD	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
withdraw	withdraw	IN	B-NP	O
800	800	CD	I-NP	O
cc	cc	NN	I-NP	O
of	of	IN	B-PP	O
clear	clear	JJ	B-NP	O
yellow	yellow	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
whose	whose	WP$	B-NP	O
chemistries	chemistry	NNS	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
count	count	NN	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sterile	sterile	JJ	I-NP	O
transudative	transudative	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Gram	Gram	NN	B-NP	B-protein
stein	stein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
repeated	repeat	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
underlying	underlie	VBG	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
revealed	reveal	VBN	B-VP	O
by	by	IN	B-PP	O
draining	drain	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
legionella	legionella	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
2.6	2.6	CD	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
possibly	possibly	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
improved	improved	JJ	B-NP	O
forward	forward	JJ	I-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

Endocrinology	Endocrinology	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
hypoglycemic	hypoglycemic	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
possibly	possibly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
infection	infection	NN	B-NP	O
or	or	CC	O	O
logistical	logistical	JJ	B-NP	O
and	and	CC	I-NP	O
social	social	JJ	I-NP	O
barriers	barrier	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
cut	cut	VBN	I-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.d.	q.d.	LS	B-LST	O
with	with	IN	B-PP	O
lispro	lispro	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
needed	need	VBD	B-VP	O
only	only	RB	B-ADVP	O
minimally	minimally	RB	I-ADVP	O
about	about	IN	B-NP	O
5	5	CD	I-NP	O
units	unit	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
which	which	WDT	B-NP	O
supports	support	VBZ	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
34	34	CD	B-NP	O
units	unit	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
too	too	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
beyond	beyond	IN	B-PP	O
a	a	DT	B-NP	O
certain	certain	JJ	I-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
known	know	VBN	B-VP	O
valvular	valvular	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
exhibiting	exhibit	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
up	up	RB	B-ADVP	O
10	10	CD	B-NP	O
pounds	pound	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
after	after	IN	B-PP	O
diuresing	diurese	VBG	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
Lipitor	Lipitor	NN	I-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
metoprolol	metoprolol	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	I-VP	O
captopril	captopril	VB	I-VP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
discontinued	discontinue	VBD	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
bumping	bumping	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
while	while	IN	B-SBAR	O
diuresing	diurese	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
hypotensive	hypotensive	JJ	I-ADJP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90s	CD	I-NP	O
to	to	TO	B-PP	O
100s	100s	CD	B-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
and	and	CC	O	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
bolus	bolus	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
,	,	,	O	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
captopril	captopril	NN	I-NP	O
and	and	CC	O	O
holding	hold	VBG	B-VP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
looks	look	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
checked	check	VBD	B-VP	O
and	and	CC	O	O
repleted	replete	VBD	B-VP	O
to	to	TO	I-VP	O
ensure	ensure	VB	I-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-NP	O
moderate	moderate	JJ	I-NP	O
everyday	everyday	JJ	I-NP	O
no	no	RB	I-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
liter	liter	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
such	such	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	O	O
loose	loose	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
overtime	overtime	NN	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	O
gammopathy	gammopathy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
microcytosis	microcytosis	NN	I-NP	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
suggest	suggest	VB	I-VP	O
thalassemia	thalassemia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
and	and	CC	I-NP	O
Epogen	Epogen	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
improved	improved	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
MCV	MCV	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
renal	renal	JJ	B-NP	O
disease	disease	NN	I-NP	O
causing	cause	VBG	B-VP	O
her	her	PRP$	B-NP	O
microcytosis	microcytosis	NN	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
monoclonal	monoclonal	JJ	I-NP	O
gammopathy	gammopathy	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
deferred	defer	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

Diabetic	Diabetic	JJ	B-NP	O
diet	diet	NN	I-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
sodium	sodium	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
Heparin	Heparin	NN	B-NP	O
and	and	CC	I-NP	O
H2	H2	NN	I-NP	O
blocker	blocker	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
screened	screen	VBN	I-VP	O
for	for	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
Jack	Jack	NNP	B-NP	O
Nor	Nor	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Of	Of	IN	B-PP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
today	today	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
intense	intense	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
learning	learn	VBG	B-VP	O
greater	great	JJR	B-NP	O
independence	independence	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
functioning	functioning	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pelvic	pelvic	JJ	I-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
fracture	fracture	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
ambulated	ambulate	VBN	I-VP	O
t.i.d.	t.i.d.	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Metoprolol	Metoprolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Amitriptyline	Amitriptyline	NN	B-NP	O
25	25	CD	I-NP	O
to	to	TO	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Multivitamins	Multivitamin	NNS	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Aspirin325	Aspirin325	NN	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	B-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
moment	moment	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.h.s.	q.h.s.	RB	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Lispro	Lispro	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	O	O
q.h.s.	q.h.s.	NN	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Epogen	Epogen	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.	q.	LS	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Ms	Ms	NNP	B-NP	O
Mengel	Mengel	NNP	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rufener	Rufener	NNP	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-PP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
or	or	CC	I-NP	O
two	two	CD	I-NP	O
.	.	.	O	O

Ellington	Ellington	NNP	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Jarrett	Jarrett	NNP	B-NP	O
Sandlan	Sandlan	NNP	I-NP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
653-609-3621	653-609-3621	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
b	b	VB	I-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Toprol	Toprol	NNP	B-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
tolerates	tolerate	VBZ	B-VP	O
and	and	CC	O	O
to	to	TO	B-VP	O
lisinopril	lisinopril	VB	I-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
tolerates	tolerate	VBZ	B-VP	O
after	after	IN	B-PP	O
low-level	low-level	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
50	50	CD	I-NP	O
cc	cc	NN	I-NP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
liter	liter	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
pending	pende	VBG	B-PP	O
include	include	VBP	B-VP	O
cytology	cytology	NN	B-NP	O
and	and	CC	I-NP	O
culture	culture	NN	I-NP	O
of	of	IN	B-PP	O
pleural	pleural	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
and	and	CC	O	O
follow-up	follow-up	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
dose	dose	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
increased	increase	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-8470788	8-8470788	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
KUFFEL	KUFFEL	NNP	B-NP	O
,	,	,	O	O
CARLOS	CARLOS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KRESHA	KRESHA	NNP	B-NP	O
,	,	,	O	O
OTIS	OTIS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0475358	0475358	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/5/05	4/5/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/5/05	4/5/05	CD	B-NP	O

